NB465144
Novus Biologicals™ VEGFR3/Flt-4 Antibody (LY3022856), Novus Biologicals™
Manufacturer: Fischer Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | NB465144-Each-of-1 | In Stock | ₹ 23,882.36 |
NB465144 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 23,882.36
GST (18%): ₹ 4,298.825
Total Price: ₹ 28,181.185
Antigen
VEGFR3/Flt-4
Classification
Monoclonal
Conjugate
Unconjugated
Gene Accession No.
P35916
Host Species
Human
Purification Method
Protein A purified
Regulatory Status
RUO
Primary or Secondary
Primary
Reconstitution
Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.
Content And Storage
Store at -20°C in powder form. Store at -80°C once reconstituted.
Isotype
IgG1
Applications
Flow Cytometry, ELISA, Functional Assay
Clone
LY3022856
Formulation
Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Gene Alias
EC 2.7.10, EC 2.7.10.1, FLT-4, fms-related tyrosine kinase 4, LMPH1A, PCLFLT41, soluble VEGFR3 variant 1, soluble VEGFR3 variant 2, soluble VEGFR3 variant 3, Tyrosine-protein kinase receptor FLT4, vascular endothelial growth factor receptor 3, VEGFR-3, VEGFR3Fms-like tyrosine kinase 4
Immunogen
VEGFR3/ FLT4
Quantity
100 μg
Research Discipline
Angiogenesis, Cancer, Hypoxia, Protein Kinase
Gene ID (Entrez)
2324
Target Species
Human
Form
Purified
Related Products
Description
- VEGFR3/Flt-4 Monoclonal antibody specifically detects VEGFR3/Flt-4 in Human samples
- It is validated for Flow Cytometry,ELISA,Functional Assay
Compare Similar Items
Show Difference
Antigen: VEGFR3/Flt-4
Classification: Monoclonal
Conjugate: Unconjugated
Gene Accession No.: P35916
Host Species: Human
Purification Method: Protein A purified
Regulatory Status: RUO
Primary or Secondary: Primary
Reconstitution: Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.
Content And Storage: Store at -20°C in powder form. Store at -80°C once reconstituted.
Isotype: IgG1
Applications: Flow Cytometry, ELISA, Functional Assay
Clone: LY3022856
Formulation: Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Gene Alias: EC 2.7.10, EC 2.7.10.1, FLT-4, fms-related tyrosine kinase 4, LMPH1A, PCLFLT41, soluble VEGFR3 variant 1, soluble VEGFR3 variant 2, soluble VEGFR3 variant 3, Tyrosine-protein kinase receptor FLT4, vascular endothelial growth factor receptor 3, VEGFR-3, VEGFR3Fms-like tyrosine kinase 4
Immunogen: VEGFR3/ FLT4
Quantity: 100 μg
Research Discipline: Angiogenesis, Cancer, Hypoxia, Protein Kinase
Gene ID (Entrez): 2324
Target Species: Human
Form: Purified
Antigen:
VEGFR3/Flt-4
Classification:
Monoclonal
Conjugate:
Unconjugated
Gene Accession No.:
P35916
Host Species:
Human
Purification Method:
Protein A purified
Regulatory Status:
RUO
Primary or Secondary:
Primary
Reconstitution:
Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.
Content And Storage:
Store at -20°C in powder form. Store at -80°C once reconstituted.
Isotype:
IgG1
Applications:
Flow Cytometry, ELISA, Functional Assay
Clone:
LY3022856
Formulation:
Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Gene Alias:
EC 2.7.10, EC 2.7.10.1, FLT-4, fms-related tyrosine kinase 4, LMPH1A, PCLFLT41, soluble VEGFR3 variant 1, soluble VEGFR3 variant 2, soluble VEGFR3 variant 3, Tyrosine-protein kinase receptor FLT4, vascular endothelial growth factor receptor 3, VEGFR-3, VEGFR3Fms-like tyrosine kinase 4
Immunogen:
VEGFR3/ FLT4
Quantity:
100 μg
Research Discipline:
Angiogenesis, Cancer, Hypoxia, Protein Kinase
Gene ID (Entrez):
2324
Target Species:
Human
Form:
Purified
Antigen: VEGFR2/KDR/Flk-1
Classification: Monoclonal
Conjugate: Unconjugated
Gene Accession No.: P35968
Host Species: Human
Purification Method: Protein A purified
Regulatory Status: RUO
Primary or Secondary: Primary
Reconstitution: Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.
Content And Storage: Store at -20°C in powder form. Store at -80°C once reconstituted.
Isotype: IgG1
Applications: Flow Cytometry, ELISA, Functional Assay
Clone: vulinacimab
Formulation: Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Gene Alias: CD309, CD309 antigen, EC 2.7.10, EC 2.7.10.1, Fetal liver kinase 1, fetal liver kinase-1, FLK-1, FLK1tyrosine kinase growth factor receptor, Kinase insert domain receptor, kinase insert domain receptor (a type III receptor tyrosine kinase), Protein-tyrosine kinase receptor flk-1, soluble VEGFR2, vascular endothelial growth factor receptor 2, VEGFR, VEGFR2, VEGFR-2
Immunogen: VEGFR2/ KDR/ CD309
Quantity: 50 μg
Research Discipline: Angiogenesis, Apoptosis, Cancer, Cell Biology, Cellular Markers, Endothelial Cell Markers, Hematopoietic Stem Cell Markers, HIF Target Genes, Hypoxia, Phospho Specific, Signal Transduction, Stem Cell Markers, Tumor Suppressors, Tyrosine Kinases
Gene ID (Entrez): 3791
Target Species: Human
Form: Purified
Antigen:
VEGFR2/KDR/Flk-1
Classification:
Monoclonal
Conjugate:
Unconjugated
Gene Accession No.:
P35968
Host Species:
Human
Purification Method:
Protein A purified
Regulatory Status:
RUO
Primary or Secondary:
Primary
Reconstitution:
Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.
Content And Storage:
Store at -20°C in powder form. Store at -80°C once reconstituted.
Isotype:
IgG1
Applications:
Flow Cytometry, ELISA, Functional Assay
Clone:
vulinacimab
Formulation:
Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Gene Alias:
CD309, CD309 antigen, EC 2.7.10, EC 2.7.10.1, Fetal liver kinase 1, fetal liver kinase-1, FLK-1, FLK1tyrosine kinase growth factor receptor, Kinase insert domain receptor, kinase insert domain receptor (a type III receptor tyrosine kinase), Protein-tyrosine kinase receptor flk-1, soluble VEGFR2, vascular endothelial growth factor receptor 2, VEGFR, VEGFR2, VEGFR-2
Immunogen:
VEGFR2/ KDR/ CD309
Quantity:
50 μg
Research Discipline:
Angiogenesis, Apoptosis, Cancer, Cell Biology, Cellular Markers, Endothelial Cell Markers, Hematopoietic Stem Cell Markers, HIF Target Genes, Hypoxia, Phospho Specific, Signal Transduction, Stem Cell Markers, Tumor Suppressors, Tyrosine Kinases
Gene ID (Entrez):
3791
Target Species:
Human
Form:
Purified
Antigen: VEGFR2/KDR/Flk-1
Classification: Monoclonal
Conjugate: Unconjugated
Gene Accession No.: P35968
Host Species: Human
Purification Method: Protein A purified
Regulatory Status: RUO
Primary or Secondary: Primary
Reconstitution: Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.
Content And Storage: Store at -20°C in powder form. Store at -80°C once reconstituted.
Isotype: IgG1
Applications: Flow Cytometry, ELISA, Functional Assay
Clone: vulinacimab
Formulation: Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Gene Alias: CD309, CD309 antigen, EC 2.7.10, EC 2.7.10.1, Fetal liver kinase 1, fetal liver kinase-1, FLK-1, FLK1tyrosine kinase growth factor receptor, Kinase insert domain receptor, kinase insert domain receptor (a type III receptor tyrosine kinase), Protein-tyrosine kinase receptor flk-1, soluble VEGFR2, vascular endothelial growth factor receptor 2, VEGFR, VEGFR2, VEGFR-2
Immunogen: VEGFR2/ KDR/ CD309
Quantity: 1 mg
Research Discipline: Angiogenesis, Apoptosis, Cancer, Cell Biology, Cellular Markers, Endothelial Cell Markers, Hematopoietic Stem Cell Markers, HIF Target Genes, Hypoxia, Phospho Specific, Signal Transduction, Stem Cell Markers, Tumor Suppressors, Tyrosine Kinases
Gene ID (Entrez): 3791
Target Species: Human
Form: Purified
Antigen:
VEGFR2/KDR/Flk-1
Classification:
Monoclonal
Conjugate:
Unconjugated
Gene Accession No.:
P35968
Host Species:
Human
Purification Method:
Protein A purified
Regulatory Status:
RUO
Primary or Secondary:
Primary
Reconstitution:
Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.
Content And Storage:
Store at -20°C in powder form. Store at -80°C once reconstituted.
Isotype:
IgG1
Applications:
Flow Cytometry, ELISA, Functional Assay
Clone:
vulinacimab
Formulation:
Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Gene Alias:
CD309, CD309 antigen, EC 2.7.10, EC 2.7.10.1, Fetal liver kinase 1, fetal liver kinase-1, FLK-1, FLK1tyrosine kinase growth factor receptor, Kinase insert domain receptor, kinase insert domain receptor (a type III receptor tyrosine kinase), Protein-tyrosine kinase receptor flk-1, soluble VEGFR2, vascular endothelial growth factor receptor 2, VEGFR, VEGFR2, VEGFR-2
Immunogen:
VEGFR2/ KDR/ CD309
Quantity:
1 mg
Research Discipline:
Angiogenesis, Apoptosis, Cancer, Cell Biology, Cellular Markers, Endothelial Cell Markers, Hematopoietic Stem Cell Markers, HIF Target Genes, Hypoxia, Phospho Specific, Signal Transduction, Stem Cell Markers, Tumor Suppressors, Tyrosine Kinases
Gene ID (Entrez):
3791
Target Species:
Human
Form:
Purified
Antigen: VEGFR2/KDR/Flk-1
Classification: Monoclonal
Conjugate: Unconjugated
Gene Accession No.: P35968
Host Species: Human
Purification Method: Protein A purified
Regulatory Status: RUO
Primary or Secondary: Primary
Reconstitution: Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.
Content And Storage: Store at -20°C in powder form. Store at -80°C once reconstituted.
Isotype: IgG1
Applications: Flow Cytometry, ELISA, Functional Assay
Clone: vulinacimab
Formulation: Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Gene Alias: CD309, CD309 antigen, EC 2.7.10, EC 2.7.10.1, Fetal liver kinase 1, fetal liver kinase-1, FLK-1, FLK1tyrosine kinase growth factor receptor, Kinase insert domain receptor, kinase insert domain receptor (a type III receptor tyrosine kinase), Protein-tyrosine kinase receptor flk-1, soluble VEGFR2, vascular endothelial growth factor receptor 2, VEGFR, VEGFR2, VEGFR-2
Immunogen: VEGFR2/ KDR/ CD309
Quantity: 100 μg
Research Discipline: Angiogenesis, Apoptosis, Cancer, Cell Biology, Cellular Markers, Endothelial Cell Markers, Hematopoietic Stem Cell Markers, HIF Target Genes, Hypoxia, Phospho Specific, Signal Transduction, Stem Cell Markers, Tumor Suppressors, Tyrosine Kinases
Gene ID (Entrez): 3791
Target Species: Human
Form: Purified
Antigen:
VEGFR2/KDR/Flk-1
Classification:
Monoclonal
Conjugate:
Unconjugated
Gene Accession No.:
P35968
Host Species:
Human
Purification Method:
Protein A purified
Regulatory Status:
RUO
Primary or Secondary:
Primary
Reconstitution:
Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.
Content And Storage:
Store at -20°C in powder form. Store at -80°C once reconstituted.
Isotype:
IgG1
Applications:
Flow Cytometry, ELISA, Functional Assay
Clone:
vulinacimab
Formulation:
Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Gene Alias:
CD309, CD309 antigen, EC 2.7.10, EC 2.7.10.1, Fetal liver kinase 1, fetal liver kinase-1, FLK-1, FLK1tyrosine kinase growth factor receptor, Kinase insert domain receptor, kinase insert domain receptor (a type III receptor tyrosine kinase), Protein-tyrosine kinase receptor flk-1, soluble VEGFR2, vascular endothelial growth factor receptor 2, VEGFR, VEGFR2, VEGFR-2
Immunogen:
VEGFR2/ KDR/ CD309
Quantity:
100 μg
Research Discipline:
Angiogenesis, Apoptosis, Cancer, Cell Biology, Cellular Markers, Endothelial Cell Markers, Hematopoietic Stem Cell Markers, HIF Target Genes, Hypoxia, Phospho Specific, Signal Transduction, Stem Cell Markers, Tumor Suppressors, Tyrosine Kinases
Gene ID (Entrez):
3791
Target Species:
Human
Form:
Purified